Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis

Anna Powell, Khalil G. Ghanem, Linda Rogers, Ashley Zinalabedini, Rebecca M. Brotman, Jonathan Zenilman, Susan Tuddenham

Research output: Contribution to journalArticle

Abstract

A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.

Original languageEnglish (US)
Pages (from-to)810-812
Number of pages3
JournalSexually transmitted diseases
Volume46
Issue number12
DOIs
StatePublished - Dec 1 2019

Fingerprint

Vulvovaginal Candidiasis
Bacterial Vaginosis
Maintenance
Patient Satisfaction
Prospective Studies
Therapeutics
boric acid

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis. / Powell, Anna; Ghanem, Khalil G.; Rogers, Linda; Zinalabedini, Ashley; Brotman, Rebecca M.; Zenilman, Jonathan; Tuddenham, Susan.

In: Sexually transmitted diseases, Vol. 46, No. 12, 01.12.2019, p. 810-812.

Research output: Contribution to journalArticle

Powell, Anna ; Ghanem, Khalil G. ; Rogers, Linda ; Zinalabedini, Ashley ; Brotman, Rebecca M. ; Zenilman, Jonathan ; Tuddenham, Susan. / Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis. In: Sexually transmitted diseases. 2019 ; Vol. 46, No. 12. pp. 810-812.
@article{f4d19a565a8a44f299a970de12c37937,
title = "Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis",
abstract = "A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.",
author = "Anna Powell and Ghanem, {Khalil G.} and Linda Rogers and Ashley Zinalabedini and Brotman, {Rebecca M.} and Jonathan Zenilman and Susan Tuddenham",
year = "2019",
month = "12",
day = "1",
doi = "10.1097/OLQ.0000000000001063",
language = "English (US)",
volume = "46",
pages = "810--812",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis

AU - Powell, Anna

AU - Ghanem, Khalil G.

AU - Rogers, Linda

AU - Zinalabedini, Ashley

AU - Brotman, Rebecca M.

AU - Zenilman, Jonathan

AU - Tuddenham, Susan

PY - 2019/12/1

Y1 - 2019/12/1

N2 - A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.

AB - A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.

UR - http://www.scopus.com/inward/record.url?scp=85075814586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075814586&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0000000000001063

DO - 10.1097/OLQ.0000000000001063

M3 - Article

C2 - 31663976

AN - SCOPUS:85075814586

VL - 46

SP - 810

EP - 812

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 12

ER -